节点文献

肿瘤病人的顺氯氨铂药代动力学研究

PHARMACOKINETIC STUDIES OF CIS-DIAMMINEDICHLOROPLATINUM IN PATIENTS WITH NEOPLASTIC DISEASE

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 彭彬赵香兰

【Author】 PENG Bin;ZHAO Xiang-Lan Department of Clinical Pharmacology, Sun Yat-Sen University of Medical Sciences, Guangzhou

【机构】 中山医科大学临床药理研究室中山医科大学临床药理研究室 广州广州

【摘要】 本文应用无火焰原子吸收光谱法测定血药浓度,对6例肿瘤患者静脉滴注顺氯氨铂(80mg/m2)的药代动力学进行了研究。研究结果表明其在血浆中的衰减呈二室开放模型,t1/2α为0.22小时,t1/2β为93.6小时。本文还注意到在给药停止后的2—8小时期间,血浆铂浓度出现回升的第二峰,提示可能是铂合物的肝——肠循环所致。根据顺氯氨铂消除半衰期较长的特点,建议化疗间歇期应在三周以上。

【Abstract】 The pharmacokinetics of cis-diamminedichloroplatinum(CDDP) was studied in 6 hospitalized patients with neoplastic diseasewho received iv infusion of CDDP(80mg/m~2). Platinum concentrations fromcis-diamminedichloroplatinum were measured in plasma by using flamelessatomic absorption spectrometric method. Plasma levels of platinum showeda biphasic clearance pattern with a rapid-phase half-life of 0. 22hr anda slow-phase half-life of 93. 6hr. A small secondary peak was noticedat 2-8 hrs after the end of the infusion, indicating the existence of anenterohepatic circulation. It is suggested that the interval between che-motherapy cycles should be 3 weeks or more because its elimination t1/2was longer.

  • 【文献出处】 中国临床药理学杂志 ,The Chinese Journal of Clinical Pharmacology , 编辑部邮箱 ,1987年01期
  • 【被引频次】17
  • 【下载频次】105
节点文献中: 

本文链接的文献网络图示:

本文的引文网络